K211872 is an FDA 510(k) clearance for the PiezoImplant System. Classified as Blade-form Endosseous Dental Implant (product code NRQ), Class II - Special Controls.
Submitted by Rex Implants, Inc. (Columbus, US). The FDA issued a Cleared decision on October 12, 2022 after a review of 482 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3640 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Dental submissions.
View all Rex Implants, Inc. devices